FDA OKs new Covid vaccine, available soon
The CDC recommends the new booster to combat the widely-circulating KP.2 strain
What happened
The Food and Drug Administration approved updated Covid-19 vaccines from Pfizer and Moderna yesterday. The new boosters target the KP.2 strain and related offshoots of the Omicron variant that have been spreading in late summer. The Centers for Disease Control and Prevention recommends the new shot for everyone six months and older.
Who said what
Last year's vaccines, which inoculated against a strain no longer in circulation, "offered moderate protection against getting infected" and a "stronger guard against severe disease," The New York Times said. When the match between virus and vaccine "is very good, as we anticipate it would be with the current circulating strains, you get actual protection from infection for several months," said Dr. Paul Sax at Brigham and Women's Hospital in Boston.
What next?
The updated vaccines should be available in pharmacies and clinics within days, at no cost to most people with health insurance and uninsured children. But "unless you're very concerned about acquiring Covid right now, my recommendation would be to get it in September or October," Dr. William Schaffner at the Vanderbilt University School of Medicine said to The Wall Street Journal. "That will provide the best protection throughout the winter season."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
The week's best photos
A helping hand, a rare dolphin and more
By Anahi Valenzuela, The Week US Published
-
Today's political cartoons - August 30, 2024
Cartoons Friday's cartoons - seasoned vets, football season, and more
By The Week US Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
The battle for abortion buffer zones
The Explainer A 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'
By Harriet Marsden, The Week UK Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
Why gonorrhoea is becoming 'untreatable'
In the Spotlight Infections hit record high as experts warn about rise in antibiotic-resistant cases
By Elizabeth Carr-Ellis, The Week UK Published
-
Where does MDMA-assisted therapy go from here?
Today's Big Question Psychedelic treatments face a challenge from the FDA
By Joel Mathis, The Week US Published
-
Can dementia be defeated?
Today's Big Question A new report identifies 14 risk factors
By Joel Mathis, The Week US Published
-
Deadly 'brain-eating' amoebas could be spreading thanks to climate change
Under the Radar Naegleria fowleri causes rare and lethal infection, but recent uptick in cases suggests it is thriving in warming waters
By Harriet Marsden, The Week UK Last updated